Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFD-01 (Sernivo) Satisfaction and Efficacy in Moderate Plaque Psoriasis
NCT02749799Phase 4Completed
- Sponsor
- Primus Pharmaceuticals
- Start
- Feb 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of betamethasone dipropionate spray 0.05% in plaque psoriasis, sponsored by Primus Pharmaceuticals. Started Feb 2016; status: completed.
02
Drugs
betamethasone dipropionate spray 0.05%
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02749799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02749799.